داروسازی لقمان
دلقما | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 9,880 1.86
Close Price: 9,720
Cash Flow
AGM
Interim
2026/06/21 Fiscal Year 2026/03/2012 Month / Audited | 2026/05/19 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | -4.924 Trillion | -5.246 Trillion | |
Income Taxes Paid | -4.704 Billion | -4.704 Billion | |
Net Cash Flow from Operating Activities | -4.929 Trillion | -5.25 Trillion | |
Purchases of Property, Plant and Equipment | -443.524 Billion | -450.882 Billion | |
Cash Paid to Acquire Long-Term Investments | -329.464 Billion | - | |
Proceeds from Sale of Investment Property | 3.751 Trillion | 3.751 Trillion | |
Cash Paid for Loans Granted to Others | -199.543 Billion | -199.543 Billion | |
Dividends Received | 78 Million | 78 Million | |
Cash Received from Income on Other Investments | 9.347 Billion | 9.347 Billion | |
Net Cash Flow from Investing Activities | 2.787 Trillion | 3.11 Trillion | |
Net Cash Flow before Financing Activities | -2.141 Trillion | -2.141 Trillion | |
Cash Received from Borrowings | 13.443 Trillion | 13.443 Trillion | |
Repayments of Borrowings (Principal) | -7.839 Trillion | -7.839 Trillion | |
Interest Paid on Borrowings | -1.374 Trillion | -1.374 Trillion | |
Dividends Paid | -686.891 Billion | -686.889 Billion | |
Net Cash Flow from Financing Activities | 3.542 Trillion | 3.542 Trillion | |
Net Increase (Decrease) in Cash | 1.401 Trillion | 1.401 Trillion | |
Cash at Beginning of Period | 974.935 Billion | 974.935 Billion | |
Effect of Exchange Rate Changes | 34.855 Billion | 35.06 Billion | |
Cash at End of Period | 1.01 Trillion | 1.01 Trillion | |
Non-Cash Transactions | 1.957 Trillion | 1.957 Trillion |